Keyphrases
Placebo
100%
Schizophrenic Patients
100%
Depot Antipsychotic
100%
Adult Patients
75%
Maintenance Phase
50%
Patients with Schizophrenia
50%
Schizophrenia
50%
Low Risk
25%
High Risk
25%
Salud
25%
Clinical Practice Guidelines
25%
Acute Phase
25%
Patient Preference
25%
Grading System
25%
Methodological Guide
25%
Hospitalization Risk
25%
Relapse Risk
25%
Oral Antipsychotics
25%
Risperidone
25%
Depot
25%
Long-acting Injectable Antipsychotics
25%
Early Weight Gain
25%
Anti-Parkinson
25%
Extrapyramidal Syndrome
25%
Paliperidone Palmitate
25%
Treatment Maintenance
25%
INIS
risks
100%
patients
100%
adults
100%
comparative evaluations
60%
maintenance
40%
recommendations
40%
guidelines
40%
injection
40%
reviews
20%
weight
20%
safety
20%
gain
20%
Nursing and Health Professions
Placebo
100%
Practice Guideline
50%
Literature Review
25%
Patient Preference
25%
Maintenance Therapy
25%
Extrapyramidal Syndrome
25%
Risperidone
25%
Paliperidone
25%
Antiparkinson Agent
25%
Adherence
25%
Medicine and Dentistry
Placebo
100%
Oral
50%
Maintenance Therapy
25%
Patient Preference
25%
Paliperidone
25%
Antiparkinson Agent
25%
Extrapyramidal Syndrome
25%
Risperidone
25%
Antipsychotic
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Antipsychotic
25%
Risperidone
25%
Paliperidone
25%
Antiparkinson Agent
25%
Extrapyramidal Syndrome
25%
Preference
25%
Neuroscience
Placebo
100%
Risperidone
25%
Paliperidone
25%
Antipsychotic
25%